Latest Pressure BioSciences Inc. Stories
Company Reaffirms Guidance for Strong Revenue Growth in FY 2015, Supported by Expected Measureable Increases in Instrument and Consumable Sales and Significant Expansion of the Company's Sales and
Forum uniquely brings together leading family offices and their foundations seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences SOUTH
Results of Studies by Three Key Opinion Leader Laboratories Demonstrate Significant Advantages in Drug Discovery, Cancer Detection, and in the Analysis of Microorganism Diversity in Soil SOUTH
Scientists from the Northwestern University's Feinberg School of Medicine Report on the Development of an Enhanced Method for Determining Fetal Exposure to Maternal Smoke and Potentially Other Environmental
Collaboration Also Will Support the New Forensic Science Program at SUNO, One of Only Four Programs in Historically Black Colleges and Universities Nationwide SOUTH EASTON, Mass.,
FY2014 Products & Services Revenue Increases 29% over FY2013; New Product Releases, NIH Grant, and Planned Expansion of Sales & Marketing Capabilities Expected to Augment Revenue in FY2015
Key Advantages in Biomarker Discovery Will be Highlighted in Two Separate Presentations at Upcoming Scientific Meeting SOUTH EASTON, Mass., March 12, 2015 /PRNewswire/ -- Pressure
Funds Will Support the Development of an Innovative, High-throughput, Automated, High Pressure-based DNA Shearing System for Next Generation Sequencing Applications SOUTH EASTON, Mass.,
Evaluation Program to End Early Following Placement of Three Additional Barozyme HT48 Systems; Accelerated Marketing Campaign to Launch Commercialization of the High-throughput PCT-based System
SOUTH EASTON, Mass., Feb. 5, 2015 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Mr. Richard T.
- The parings of haberdine; also, any kind of fragments.